Skip to main content
SpringerLink
Log in

Development of pertussis vaccine production and control in the National Institute of Public Health in the Netherlands during the years 1950–1962

  • Published:
Antonie van Leeuwenhoek Aims and scope Submit manuscript

Abstract

The development of the pertussis vaccine production in the National Institute of Public Health in the Netherlands since 1953, and the results with the consecutive lots of vaccine in the mouse protection test and the U.S.A. toxicity test are described. The results in the latter test are compared with the results of a locally developed guinea pig toxicity test. Special attention is given to the difficulties encountered when the U.S.A. toxicity test is used for adsorbed DPT vaccines. The potency data of all lots of DPT vaccines produced since 1958 fall within the limits of the potency test as prescribed in the U.S.A. Minimum Requirements. There are indications that the increased potency of the vaccine may have led to a lower mortality rate of pertussis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bos, G. J. 1960. Een epidemie van kinkhoest in een redelijk gevaccineerde huisartsenpraktijk. Huisarts en Wetenschap3: 293–297.

    Google Scholar 

  • Cohen, H. H., andLeppink G. J. 1956. Selection ofHemophilus pertussis strains for vaccine production in the mouse protection test in a balanced design. J. Immunol.77: 299–304.

    PubMed  Google Scholar 

  • Cohen, H. H. 1958. Establishment of a dried standard pertussis vaccine. Antonie van Leeuwenhoek24: 33–48.

    PubMed  Google Scholar 

  • Cohen, H. H. 1962. Discussion on the preparation of a semipurified protective antigen ofBordetella pertussis in connection with side effects and the serological response after vaccination and disease. Round Table Conference on Pertussis Immunization, Prague, Vol. 1, 97–103.

    Google Scholar 

  • van Hemert, P. andCohen, H. H. 1962. Development of agglutinogens, protective antigens and histamine sensitizing factor during continuous culture. Round Table Conference on Pertussis Immunization, Prague, Vol. 1, 24–29.

    Google Scholar 

  • Joo, I., Pusztai, Z. andJuhász, V. P. 1961a. Histamine-sensitizing activity of various pertussis vaccines. Immun. Forsch.121: 143–158.

    Google Scholar 

  • Joo, I., Pusztai, Z. andJuhász, V. P. 1961b. Comparative investigations into the mouse-protective potency, histamine-sensitizing activity and agglutinin-producing ability of pertussis vaccines. Immun. Forsch.121: 250–266.

    Google Scholar 

  • Munoz, J., Ribi, E. andLarson, C. L. 1959. Antigens ofBordetella pertussis. I. Activities of cell walls and protoplasm. J. Immunol.83: 496–501.

    PubMed  Google Scholar 

  • Piersma, H. D. 1962. Recent laboratory experience in the U.S.A. with the pertussis toxicity test. Round Table Conference on Pertussis Immunization, Prague, Vol. 1, 111–119.

    Google Scholar 

  • Pittman, M., 1951. Comparison of the histamine-sensitizing property with the protective activity of pertussis vaccines for mice. J. infect. Dis.89: 300–304.

    PubMed  Google Scholar 

  • Preston, N. W. 1959. Factors influencing the assay of the histamine-sensitising factor ofHaemophilus pertussis. J. Path. Bact.78: 217–224.

    PubMed  Google Scholar 

  • Report to the Whooping-cough Immunization Committee of the Medical Research Council, 1956. Vaccination against whooping-cough. Brit. Med. J.II: 454–462.

    Google Scholar 

  • Smeenk, C. S. 1952. Resultaat van de kinkhoest-immunisatie bij zuigelingen. Ned. T. Geneesk.96: 1812–1814.

    PubMed  Google Scholar 

  • Spronk, M. G. 1951. Actieve immunisatie tegen kinkhoest. Thesis. Amsterdam.

  • Sutherland, I. W. 1962. The cell wall ofBordetella pertussis as a protective antigen. Round Table Conference on Immunization, Prague, Vol. 1, 72–80.

    Google Scholar 

  • Tasman, A. 1959. Het verband tussen de aard van de gebruikte entstof, de wijze van inspuiten en de ent-reacties na immunisatie tegen kinkhoest, difterie en tetanus. Ned. T. Geneesk.103: 1049–1057.

    PubMed  Google Scholar 

  • Verwey, W. F., Thiele, E. H., Sage, D. N. andSchuchardt, L. F. 1949. A simplified liquid culture medium for the growth ofHemophilus pertussis. J. Bacteriol.58: 127–134.

    Google Scholar 

  • Vos, A. J. 1961. Een beschouwing over de preventieve waarde van het kinkhoestvaccin naar aanleiding van een onderzoek in een algemene praktijk. Huisarts en Wetenschap4: 114–117.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute of Public Health, Utrecht, The Netherlands

    H. H. Cohen

Authors
  1. H. H. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cohen, H.H. Development of pertussis vaccine production and control in the National Institute of Public Health in the Netherlands during the years 1950–1962. Antonie van Leeuwenhoek 29, 183–201 (1963). https://doi.org/10.1007/BF02046052

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02046052

Keywords

Search

Navigation